Skip to content

Intervention study examining the effects of fish oil supplementation on PFAS-related health risks in humans

Intervention study examining the effects of fish oil supplementation on PFAS-related health risks in humans

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500103491
Enrollment
Unknown
Registered
2025-05-29
Start date
2025-09-01
Completion date
Unknown
Last updated
2025-06-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver injury

Interventions

Occupational exposure group:Fish oil supplements
Non-occupational exposure group:Fish oil supplements

Sponsors

Zhejiang Provincial Center for Disease Control and Prevention
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1 Occupational exposure group: Workers employed in the fluorine chemical factory for =1 continuous year; Non-occupational exposure group: Staff from the same facility without direct exposure; 2 No intake of fish oil supplements within the past 3 months, and no additional supplement use during the study unless necessary; 3 No acute/chronic diseases, no intellectual or severe physical disabilities; voluntary participation with signed informed consent.

Exclusion criteria

Exclusion criteria: 1 Individuals with severe liver diseases (e.g., cirrhosis, acute liver injury, hepatitis), severe kidney disease, chronic conditions (e.g., diabetes, hypertension, cancer), HIV/AIDS, or autoimmune disorders; 2 Those who have taken medications for blood glucose, lipids, blood pressure, or anti-inflammatory purposes within the past 3 months before enrollment; 3 Individuals with a history of consuming dietary supplements (e.g., vitamins, folic acid, probiotics, calcium tablets, protein powder) within the past 3 months prior to enrollment.

Design outcomes

Secondary

MeasureTime frame
Fasting blood glucose;Insulin;Gut microbiota;

Primary

MeasureTime frame
Serum PFAS;Serum biochemical parameters;Serum EPA/DHA;

Countries

China

Contacts

Public ContactZhijian Chen

Zhejiang Provincial Center for Disease Control and Prevention

zhjchen@cdc.zj.cn+86 571 8711 5219

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026